Beneficient BENF.OQ BENF.O is expected to report resultson August 8 (estimated) for the period ending March 31 2025
The Dallas Texas-based company is expected to report revenue of $15.619 million, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Beneficient is for a loss of 59 cents per share.
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Beneficient is $2.00, about 85.7% above its last closing price of $0.29
This summary was machine generated August 8 at 13:35 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)